22.05.2017 Views

Review of Pharmacology - 9E (2015)

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Review</strong> <strong>of</strong> <strong>Pharmacology</strong><br />

MULTIPLE CHOICE QUESTIONS<br />

Cardiovascular System<br />

CONGESTIVE HEART FAILURE<br />

1. Which among the following is the best inotrope drug<br />

for use in right heart failure? (All India 2011)<br />

(a) Dobutamine<br />

(b) Digoxin<br />

(c) Dopamine<br />

(d) Milrinone<br />

2. All <strong>of</strong> the following are seen in digitalis toxicity<br />

except: (All India 2011)<br />

(a) Ventricular bigeminy<br />

(b) Paroxysmal atrial tachycardia with fast ventricular<br />

rate<br />

(c) Regularization <strong>of</strong> atrial fibrillation<br />

(d) Bidirectional ventricular tachycardia<br />

3. All are true about starting <strong>of</strong> beta-blocker therapy in a<br />

patient with congestive heart failure except:<br />

(AIIMS Nov 2010)<br />

(a) They should be started with optimum doses<br />

(b) They should be gradually increased over weeks<br />

(c) Special precautions should be taken in cases <strong>of</strong><br />

NYHA class III and IV<br />

(d) Carvedilol and metoprolol are the preferred drugs.<br />

4. The positive inotropic effect <strong>of</strong> digitalis is due to<br />

inhibition <strong>of</strong> Na + /K + ATPase pump in cardiac muscle<br />

cell membrane leading to: (DPG 2011)<br />

(a) Decreased activity <strong>of</strong> Na + /Ca ++ exchanger causing<br />

decreased influx <strong>of</strong> sodium and decreased efflux <strong>of</strong><br />

Ca ++ in the sarcolemma<br />

(b) Decreased efflux <strong>of</strong> Na + leading to less negative<br />

resting membrane potential and opening <strong>of</strong> voltage<br />

gated Ca ++ channels on the T tubules<br />

(c) Increased intracellular Na + causing increased efflux<br />

<strong>of</strong> Na + and increased influx <strong>of</strong> Ca ++ through Na + /<br />

Ca ++ exchanger in the sarcolemma<br />

(d) Increased intracellular Na + decreasing the activity <strong>of</strong><br />

Ca ++ pump in the sarcoplasmic reticulum<br />

5. All <strong>of</strong> the following drugs are used for the treatment <strong>of</strong><br />

congestive heart failure except: (AIIMS Nov 2009<br />

(a) Nitroglycerine<br />

(b) Spironolactone<br />

(c) Nesiritide<br />

(d) Trimetazidine<br />

6. Digoxin toxicity is increased by all except:<br />

(AIIMS May 2010, 2009) (AIIMS Nov 2008) (DNB 2008)<br />

(a) Renal impairment<br />

(b) Hyperkalemia<br />

(c) Hypercalcemia<br />

(d) Hypomagnesemia<br />

7. Which <strong>of</strong> the following is a venodilator? (DPG 2009)<br />

(a) Hydralazine<br />

(b) Minoxidil<br />

(c) Nitroprusside<br />

(d) Nifedipine<br />

8. All <strong>of</strong> the following statements about nesiritide are true<br />

EXCEPT: (AI 2007, AI 2005)<br />

(a) It is a BNP analogue<br />

(b) It can be used in decompensated CHF<br />

(c) It can be administered orally<br />

(d) It causes loss <strong>of</strong> Na + in the urine<br />

9. The following drugs have significant drug interactions<br />

with digoxin except: (AI 2005)<br />

(a) Cholestyramine<br />

(b) Thiazide diuretics<br />

(c) Quinidine<br />

(d) Amlodipine<br />

10. Digoxin is contraindicated in: (AI 2002)<br />

(a) Supraventricular tachycardia<br />

(b) Atrial fibrillation<br />

(c) Congestive heart failure<br />

(d) Hypertrophic obstructive cardiomyopathy<br />

11. Digoxin is not indicated in: (AI 2001)<br />

(a) Atrial flutter<br />

(b) Atrial fibrillation<br />

(c) High output failure<br />

(d) PSVT<br />

12. Digoxin action is not affected in: (AIIMS May, 2007)<br />

(a) Hepatic disease<br />

(b) Electrolyte disturbances<br />

(c) Renal failure<br />

(d) MI<br />

13. BNP is degraded by: (AIIMS May, 2007)<br />

(a) Neutral endopeptidase<br />

(b) Elastase<br />

(c) Omapatrilat<br />

(d) ACE<br />

14. Drugs used in CHF are: (PGI June, 2007)<br />

(a) Nesiritide<br />

(b) Digoxin<br />

(c) Spironolactone<br />

(d) Losartan<br />

(e) Adrenaline<br />

176<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!